Variations in the Hemagglutinin of the 2009 H1N1 Pandemic Virus: Potential for Strains with Altered Virulence Phenotype?
A novel, swine-origin influenza H1N1 virus (H1N1pdm) caused the first pandemic of the 21st century. This pandemic, although efficient in transmission, is mild in virulence. This atypical mild pandemic season has raised concerns regarding the potential of this virus to acquire additional virulence markers either through further adaptation or possibly by immune pressure in the human host. Using the mouse model we generated, within a single round of infection with A/California/04/09/H1N1 (Ca/04), a virus lethal in mice—herein referred to as mouse-adapted Ca/04 (ma-Ca/04). Five amino acid substitutions were found in the genome of ma-Ca/04: 3 in HA (D131E, S186P and A198E), 1 in PA (E298K) and 1 in NP (D101G). Reverse genetics analyses of these mutations indicate that all five mutations from ma-Ca/04 contributed to the lethal phenotype; however, the D131E and S186P mutations—which are also found in the 1918 and seasonal H1N1 viruses—in HA alone were sufficient to confer virulence of Ca/04 in mice. HI assays against H1N1pdm demonstrate that the D131E and S186P mutations caused minor antigenic changes and, likely, affected receptor binding. The rapid selection of ma-Ca/04 in mice suggests that a virus containing this constellation of amino acids might have already been present in Ca/04, likely as minor quasispecies.
Vyšlo v časopise:
Variations in the Hemagglutinin of the 2009 H1N1 Pandemic Virus: Potential for Strains with Altered Virulence Phenotype?. PLoS Pathog 6(10): e32767. doi:10.1371/journal.ppat.1001145
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001145
Souhrn
A novel, swine-origin influenza H1N1 virus (H1N1pdm) caused the first pandemic of the 21st century. This pandemic, although efficient in transmission, is mild in virulence. This atypical mild pandemic season has raised concerns regarding the potential of this virus to acquire additional virulence markers either through further adaptation or possibly by immune pressure in the human host. Using the mouse model we generated, within a single round of infection with A/California/04/09/H1N1 (Ca/04), a virus lethal in mice—herein referred to as mouse-adapted Ca/04 (ma-Ca/04). Five amino acid substitutions were found in the genome of ma-Ca/04: 3 in HA (D131E, S186P and A198E), 1 in PA (E298K) and 1 in NP (D101G). Reverse genetics analyses of these mutations indicate that all five mutations from ma-Ca/04 contributed to the lethal phenotype; however, the D131E and S186P mutations—which are also found in the 1918 and seasonal H1N1 viruses—in HA alone were sufficient to confer virulence of Ca/04 in mice. HI assays against H1N1pdm demonstrate that the D131E and S186P mutations caused minor antigenic changes and, likely, affected receptor binding. The rapid selection of ma-Ca/04 in mice suggests that a virus containing this constellation of amino acids might have already been present in Ca/04, likely as minor quasispecies.
Zdroje
1. LibsterR
BugnaJ
CovielloS
HijanoDR
DunaiewskyM
2010 Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med 362 45 55
2. LouieJK
AcostaM
WinterK
JeanC
GavaliS
2009 Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 302 1896 1902
3. DonaldsonLJ
RutterPD
EllisBM
GreavesFE
MyttonOT
2009 Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 339 b5213
4. XuR
EkiertDC
KrauseJC
HaiR
CroweJEJr
2010 Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328 357 360
5. HattaM
GaoP
HalfmannP
KawaokaY
2001 Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293 1840 1842
6. ConenelloGM
ZamarinD
PerroneLA
TumpeyT
PaleseP
2007 A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 3 1414 1421
7. JacksonD
HossainMJ
HickmanD
PerezDR
LambRA
2008 A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci U S A 105 4381 4386
8. HaiR
SchmolkeM
VargaZT
ManicassamyB
WangTT
2010 PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J Virol 84 4442 4450
9. HerfstS
ChutinimitkulS
YeJ
de WitE
MunsterVJ
2010 Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission. J Virol 84 3752 3758
10. TaubenbergerJK
ReidAH
FanningTG
2000 The 1918 influenza virus: A killer comes into view. Virology 274 241 245
11. VincentAL
MaW
LagerKM
JankeBH
RichtJA
2008 Swine influenza viruses a North American perspective. Adv Virus Res 72 127 154
12. MillerRR
MacLeanAR
GunsonRN
CarmanWF
2010 Occurrence of haemagglutinin mutation D222G in pandemic influenza A(H1N1) infected patients in the West of Scotland, United Kingdom, 2009-10. Euro Surveill 15
13. MakGC
AuKW
TaiLS
ChuangKC
ChengKC
2010 Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease. Euro Surveill 15
14. PotdarVA
ChadhaMS
JadhavSM
MullickJ
CherianSS
2010 Genetic characterization of the influenza A pandemic (H1N1) 2009 virus isolates from India. PLoS ONE 5 e9693
15. KilanderA
RykkvinR
DudmanSG
HungnesO
2010 Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill 15
16. 2010 Preliminary review of D222G amino acid substitution in the haemagglutinin of pandemic influenza A (H1N1) 2009 viruses. Wkly Epidemiol Rec 85 21 22
17. BoonAC
deBeauchampJ
HollmannA
LukeJ
KotbM
2009 Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J Virol 83 10417 10426
18. SrivastavaB
BlazejewskaP
HessmannM
BruderD
GeffersR
2009 Host genetic background strongly influences the response to influenza a virus infections. PLoS One 4 e4857
19. ItohY
ShinyaK
KisoM
WatanabeT
SakodaY
2009 In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460 1021 1025
20. MunsterVJ
de WitE
van den BrandJM
HerfstS
SchrauwenEJ
2009 Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325 481 483
21. TumpeyTM
BaslerCF
AguilarPV
ZengH
SolorzanoA
2005 Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310 77 80
22. HermannG
TovarCA
BeckFM
AllenC
SheridanJF
1993 Restraint stress differentially affects the pathogenesis of an experimental influenza viral infection in three inbred strains of mice. J Neuroimmunol 47 83 94
23. PerezD
SorrellE
AngelM
YeJ
HickmanD
2009 Fitness of Pandemic H1N1 and Seasonal influenza A viruses during Co-infection: Evidence of competitive advantage of pandemic H1N1 influenza versus seasonal influenza. PLoS Curr Influenza RRN1011
24. GamblinSJ
HaireLF
RussellRJ
StevensDJ
XiaoB
2004 The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303 1838 1842
25. StevensJ
CorperAL
BaslerCF
TaubenbergerJK
PaleseP
2004 Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 303 1866 1870
26. SmeenkCA
WrightKE
BurnsBF
ThakerAJ
BrownEG
1996 Mutations in the hemagglutinin and matrix genes of a virulent influenza virus variant, A/FM/1/47-MA, control different stages in pathogenesis. Virus Res 44 79 95
27. SmeenkCA
BrownEG
1994 The influenza virus variant A/FM/1/47-MA possesses single amino acid replacements in the hemagglutinin, controlling virulence, and in the matrix protein, controlling virulence as well as growth. J Virol 68 530 534
28. GartenRJ
DavisCT
RussellCA
ShuB
LindstromS
2009 Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325 197 201
29. IgarashiM
ItoK
YoshidaR
TomabechiD
KidaH
2010 Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS ONE 5 e8553
30. SongH
NietoGR
PerezDR
2007 A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates. J Virol 81 9238 9248
31. MainesTR
JayaramanA
BelserJA
WadfordDA
PappasC
2009 Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325 484 487
32. Al HajjarS
McIntoshK
2010 The first influenza pandemic of the 21st century. Ann Saudi Med 30 1 10
33. GillJR
ShengZM
ElySF
GuineeDG
BeasleyMB
2010 Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 134 235 243
34. LyonJB
RemigioC
MilliganT
DelineC
2010 Acute necrotizing encephalopathy in a child with H1N1 influenza infection. Pediatr Radiol 40 200 205
35. BaltagiSA
ShoykhetM
FelmetK
KochanekPM
BellMJ
2010 Neurological sequelae of 2009 influenza A (H1N1) in children: a case series observed during a pandemic. Pediatr Crit Care Med 11 179 184
36. KumarA
ZarychanskiR
PintoR
CookDJ
MarshallJ
2009 Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 302 1872 1879
37. HensleySE
DasSR
BaileyAL
SchmidtLM
HickmanHD
2009 Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326 734 736
38. MunsterVJ
de WitE
van den BrandJM
HerfstS
SchrauwenEJ
2009 Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets. Science
39. ReedLJ
MuenchH
1938 A simple method for estimating 50 percent endpoints. Am J Hyg 37 493
40. WanH
SorrellEM
SongH
HossainMJ
Ramirez-NietoG
2008 Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. PLoS ONE 3 e2923
41. SorrellEM
WanH
ArayaY
SongH
PerezDR
2009 Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus. Proc Natl Acad Sci U S A
42. HoffmannE
StechJ
GuanY
WebsterRG
PerezDR
2001 Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146 2275 2289
43. HoffmannE
KraussS
PerezD
WebbyR
WebsterRG
2002 Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20 3165 3170
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 10
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Retroviral RNA Dimerization and Packaging: The What, How, When, Where, and Why
- Viral Replication Rate Regulates Clinical Outcome and CD8 T Cell Responses during Highly Pathogenic H5N1 Influenza Virus Infection in Mice
- Antimicrobial Peptides: Primeval Molecules or Future Drugs?
- Crystal Structure of DotD: Insights into the Relationship between Type IVB and Type II/III Secretion Systems